Therapeutic effects of lomerizine on vasculopathy in Fabry disease.

Sci Rep · 2025 · PMC11965366 · PMID 40175492

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Notably, lomerizine treatment showed a trend toward reducing blood creatinine levels, suggesting a potential improvement in renal function (Supplementary Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.